{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:52:14Z","timestamp":1781700734633,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30770912"],"award-info":[{"award-number":["30770912"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400123"],"award-info":[{"award-number":["81400123"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation of the Science & Technology Department of Sichuan Province","award":["2013SZ0025"],"award-info":[{"award-number":["2013SZ0025"]}]},{"name":"Doctoral Tutor Fund of Ministry of Education","award":["20120181110008"],"award-info":[{"award-number":["20120181110008"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.biocel.2015.05.003","type":"journal-article","created":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T12:49:44Z","timestamp":1431434984000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT\/mTOR pathway and BCR\/ABL gene expression in Ph+ acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"65","author":[{"given":"Yong","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangcui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2015.05.003_bib0175","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/mol.105.017400","article-title":"Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation","volume":"69","author":"Aggarwal","year":"2006","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.biocel.2015.05.003_bib0170","doi-asserted-by":"crossref","first-page":"6301","DOI":"10.1074\/jbc.M410647200","article-title":"Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine\/threonine kinase Akt and is independent of tubulin polymerization","volume":"280","author":"Bava","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2015.05.003_bib0180","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/ijc.21932","article-title":"Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells","volume":"119","author":"Beevers","year":"2006","journal-title":"International Journal of Cancer Journal International du Cancer"},{"key":"10.1016\/j.biocel.2015.05.003_bib0185","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1158\/0008-5472.CAN-08-2367","article-title":"Curcumin disrupts the Mammalian target of rapamycin-raptor complex","volume":"69","author":"Beevers","year":"2009","journal-title":"Cancer Research"},{"key":"10.1016\/j.biocel.2015.05.003_bib0190","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-6997(25)00026-2","article-title":"What is synergy?","volume":"41","author":"Berenbaum","year":"1989","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.biocel.2015.05.003_bib0085","first-page":"461","article-title":"Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance","author":"Bixby","year":"2009","journal-title":"Hematology\/the Education Program of the American Society of Hematology American Society of Hematology Education Program"},{"key":"10.1016\/j.biocel.2015.05.003_bib0130","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1182\/blood-2010-08-301267","article-title":"Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"117","author":"Boulos","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2015.05.003_bib0095","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1038\/sj.leu.2403898","article-title":"Compensatory PI3-kinase\/Akt\/mTor activation regulates imatinib resistance development","volume":"19","author":"Burchert","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.biocel.2015.05.003_bib0055","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1182\/blood-2002-03-0704","article-title":"Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia\u2014results of the prospective multicenter LALA-94 trial","volume":"100","author":"Dombret","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2015.05.003_bib0075","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome","volume":"344","author":"Druker","year":"2001","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.biocel.2015.05.003_bib0020","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/cncr.11664","article-title":"The biology and therapy of adult acute lymphoblastic leukemia","volume":"98","author":"Faderl","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.biocel.2015.05.003_bib0145","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/01635581.2010.509835","article-title":"Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs","volume":"62","author":"Goel","year":"2010","journal-title":"Nutrition and Cancer"},{"key":"10.1016\/j.biocel.2015.05.003_bib0065","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2141.2009.07666.x","article-title":"Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia","volume":"145","author":"Gruber","year":"2009","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.biocel.2015.05.003_bib0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biocel.2015.05.003_bib0110","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.4161\/cbt.21460","article-title":"Oridonin in combination with imatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN\/mTOR signaling pathway","volume":"13","author":"Guo","year":"2012","journal-title":"Cancer Biology & Therapy"},{"key":"10.1016\/j.biocel.2015.05.003_bib0060","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/leu.2009.38","article-title":"Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia","volume":"23","author":"Hochhaus","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.biocel.2015.05.003_bib0030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ng1343","article-title":"Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia","volume":"36","author":"Hu","year":"2004","journal-title":"Nature Genetics"},{"key":"10.1016\/j.biocel.2015.05.003_bib0050","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2141.2005.05611.x","article-title":"Philadelphia positive acute lymphoblastic leukaemia of childhood","volume":"130","author":"Jones","year":"2005","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.biocel.2015.05.003_bib0150","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.canlet.2008.03.009","article-title":"Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins","volume":"269","author":"Kunnumakkara","year":"2008","journal-title":"Cancer Letters"},{"key":"10.1016\/j.biocel.2015.05.003_bib0025","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.2408149","article-title":"Tyrosine kinase activity and transformation potency of bcr-abl oncogene products","volume":"247","author":"Lugo","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.biocel.2015.05.003_bib0045","doi-asserted-by":"crossref","first-page":"30907","DOI":"10.1074\/jbc.M605902200","article-title":"Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity","volume":"281","author":"Meyn","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2015.05.003_bib0015","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","article-title":"Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2015.05.003_bib0080","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1182\/blood-2001-12-0181","article-title":"A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias","volume":"100","author":"Ottmann","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2015.05.003_bib0120","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1182\/blood-2007-02-073528","article-title":"Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study","volume":"110","author":"Ottmann","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2015.05.003_bib0005","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1517\/14712598.6.10.1011","article-title":"Advances and potential treatment for Philadelphia chromosome-positive adult acute lymphoid leukaemia","volume":"6","author":"Piccaluga","year":"2006","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1016\/j.biocel.2015.05.003_bib0140","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/leu.2008.10","article-title":"Long-term molecular complete remission with IFN-alpha in Ph+ adult acute lymphoid leukemia patients","volume":"22","author":"Piccaluga","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.biocel.2015.05.003_bib0010","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.biocel.2015.05.003_bib0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1200\/JCO.2008.19.8853","article-title":"Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR\/ABL mutants","volume":"27","author":"Redaelli","year":"2009","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.biocel.2015.05.003_bib0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0950-3536(97)80004-2","article-title":"Signal transduction pathways involved in BCR-ABL transformation","volume":"10","author":"Sawyers","year":"1997","journal-title":"Bailliere's Clinical Haematology"},{"key":"10.1016\/j.biocel.2015.05.003_bib0070","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1200\/JCO.2008.21.2514","article-title":"Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study","volume":"27","author":"Schultz","year":"2009","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.biocel.2015.05.003_bib0040","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1093\/emboj\/16.20.6151","article-title":"Transformation of hematopoietic cells by BCR\/ABL requires activation of a PI-3k\/Akt-dependent pathway","volume":"16","author":"Skorski","year":"1997","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.biocel.2015.05.003_bib0090","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1158\/1078-0432.CCR-06-1516","article-title":"Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia","volume":"12","author":"Soverini","year":"2006","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/j.biocel.2015.05.003_bib0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-0609.2009.01387.x","article-title":"BCR-ABL-independent and RAS\/MAPK pathway-dependent form of imatinib resistance in Ph-positive acute lymphoblastic leukemia cell line with activation of EphB4","volume":"84","author":"Suzuki","year":"2010","journal-title":"European Journal of Haematology"},{"key":"10.1016\/j.biocel.2015.05.003_bib0125","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood-2006-10-052746","volume":"109","author":"Vignetti","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2015.05.003_bib0135","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.leu.2403093","article-title":"Efficacy and safety of imatinib mesylate (Glivec) in combination with interferon-alpha (IFN-alpha) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)","volume":"17","author":"Wassmann","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.biocel.2015.05.003_bib0165","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/carcin\/bgg082","article-title":"Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt","volume":"24","author":"Woo","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biocel.2015.05.003_bib0100","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/jnci\/djn188","article-title":"Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinase","volume":"100","author":"Wu","year":"2008","journal-title":"Journal of the National Cancer Institute"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272515001247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272515001247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:02:15Z","timestamp":1761202935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272515001247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":37,"alternative-id":["S1357272515001247"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2015.05.003","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT\/mTOR pathway and BCR\/ABL gene expression in Ph+ acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2015.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}